LWM
PCRX icon

Liberty Wealth Management’s Pacira BioSciences PCRX Stock Holding History

Liberty Wealth Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-142
Closed -$8K – 828
2021
Q3 		$8K Buy
142
+76
+115% +$4.38K ﹤0.01% 872
2021
Q2 		$4K Hold
66
– – ﹤0.01% 839
2021
Q1 		$4K Hold
66
– – ﹤0.01% 741
2020
Q4 		$4K Buy
66
+2
+3% +$117 ﹤0.01% 737
2020
Q3 		$4K Buy
+64
New +$3.72K ﹤0.01% 663

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Liberty Wealth Management's PCRX Position: Q4 2021 in Review

Liberty Wealth Management sold out of Pacira BioSciences (PCRX) in Q4 2021, closing a stake of 142 shares — an estimated $8K sold.

Liberty Wealth Management first reported a position in PCRX in Q3 2020 and held it in 5 quarters. The position peaked at $8K in Q3 2021. 276 funds tracked by Wall St. Rank hold PCRX as of Q4 2021.

  • Liberty Wealth Management reported no remaining Pacira BioSciences position as of Q4 2021 after selling out during the quarter.
  • Liberty Wealth Management sold 142 Pacira BioSciences shares in Q4 2021, an estimated $8K.
  • Liberty Wealth Management first reported a position in Pacira BioSciences in Q3 2020 and held it in 5 quarters.
  • Liberty Wealth Management's Pacira BioSciences position peaked at $8K in Q3 2021.
  • 276 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2021.

Based on Liberty Wealth Management's 13F filing for Q4 2021, filed 15 Feb 2022.